Caldera Medical
Private Company
Total funding raised: $90M
Overview
Caldera Medical is a private, commercial-stage medical device company specializing in minimally invasive surgical products for women's pelvic health, specifically stress urinary incontinence, pelvic organ prolapse, and hysteroscopic procedures. The company differentiates itself through a patient-centric culture, a commitment to physician education, and the largest humanitarian program in women's health, aiming to treat one million underserved women by 2027. As the self-described fastest-growing women's health company for the past three years, Caldera leverages surgeon feedback for product improvement and maintains a portfolio of trusted, advanced solutions. Its headquarters are in Agoura Hills, California.
Technology Platform
Portfolio of minimally invasive surgical medical devices for treating Stress Urinary Incontinence (SUI), Pelvic Organ Prolapse (POP), and performing hysteroscopic tissue removal (e.g., for polyps and fibroids).
Funding History
4Opportunities
Risk Factors
Competitive Landscape
Caldera competes in the women's health medical device space against large, diversified medtech giants like Boston Scientific, Coloplast, and Johnson & Johnson's Ethicon division. Its competitive strategy relies on a focused product portfolio, strong surgeon relationships, a mission-driven culture, and a unique humanitarian program rather than competing solely on scale or price.